Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 - 17 years.

INTRODUCTION: The introduction of pneumococcal conjugate vaccines into infant immunization schedules has successfully reduced the incidence of pneumococcal disease caused by vaccine serotypes. Disease incidence is low in healthy 6 - 17-year-old children and young people; however, there are a number...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Mitchell, R, Trück, J, Pollard, A
Format: Journal article
Sprog:English
Udgivet: 2013

Lignende værker